Ribavirin 68475-0003-04
- Manufacturer
- Navinta Llc
- Dosage Form
- Powder, For Solution
- Route
- Respiratory (inhalation)
- Product Type
- Human Prescription Drug
- Marketing Start
- April 21, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA207366
Need to source Ribavirin? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ribavirin | 6 g/1 |
Drug Class
Nucleoside Analog Antiviral [EPC]Nucleoside Analog Antiviral [EPC]Nucleoside Analog [EXT]
Selected Package
68475-0003-04Selected4 VIAL in 1 CARTON (68475-003-04) / 1 POWDER, FOR SOLUTION in 1 VIAL